These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined anti-inflammatory and low-dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Reimer A; Lu S; He Y; Bruckner-Tuderman L; Technau-Hafsi K; Meiss F; Has C; von Bubnoff D J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e1-e3. PubMed ID: 31374134 [No Abstract] [Full Text] [Related]
4. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl. Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079 [TBL] [Abstract][Full Text] [Related]
5. Cemiplimab treatment of squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Vasilev P; Kalev D; Karamanliev M; Dimitrov D; Troyanova P; Yordanova I J Dtsch Dermatol Ges; 2023 Mar; 21(3):295-297. PubMed ID: 36855845 [No Abstract] [Full Text] [Related]
6. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa]. Fourel E; Claudy AL Ann Dermatol Venereol; 1992; 119(8):563-5. PubMed ID: 1485760 [TBL] [Abstract][Full Text] [Related]
7. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis. Csikós M; Orosz Z; Bottlik G; Szöcs H; Szalai Z; Rozgonyi Z; Hársing J; Török E; Bruckner-Tuderman L; Horváth A; Kárpáti S Clin Exp Dermatol; 2003 Mar; 28(2):163-6. PubMed ID: 12653705 [TBL] [Abstract][Full Text] [Related]
8. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. Kim M; Li M; Intong LR; Tran K; Melbourne W; Marucci D; Bucci J; de Souza P; Mallesara G; Murrell DF Br J Dermatol; 2013 Jul; 169(1):208-10. PubMed ID: 23398414 [No Abstract] [Full Text] [Related]
9. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases. Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient. Tomita Y; Sato-Matsumura KC; Sawamura D; Matsumura T; Shimizu H Acta Derm Venereol; 2003; 83(3):225-6. PubMed ID: 12816163 [No Abstract] [Full Text] [Related]
11. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma. Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103 [TBL] [Abstract][Full Text] [Related]
12. Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections and repairs in 2 patients. Buonocore SD; Ariyan S Ann Plast Surg; 2009 Sep; 63(3):297-9. PubMed ID: 19692898 [TBL] [Abstract][Full Text] [Related]
13. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919 [TBL] [Abstract][Full Text] [Related]
19. Epidermolysis bullosa dystrophica of Hallopeau-Siemens and squamous-cell carcinoma: a case report. Van Rengen A; Degreef H Dermatology; 1996; 192(4):418-9. PubMed ID: 8864399 [TBL] [Abstract][Full Text] [Related]
20. Electrochemotherapy, a potential new treatment for the management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases. Diociaiuti A; Rotunno R; El Hachem M; Latorre S; Cozza R; Curatolo P J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1195-6. PubMed ID: 25758658 [No Abstract] [Full Text] [Related] [Next] [New Search]